ZURICH (Reuters) – The U.S. Fda (FDA) provided emergency authorization for a much faster coronavirus test made by Swiss diagnostics maker Roche ( ROG.S), a relocation targeted at boosting screening capability to help contain the growing epidemic.
The brand-new tests supply results in 3.5 hours and can produce up to 4,128 results daily, the Basel-based business said on Friday, an increase to tests the business has provided previously.
The FDA’s Emergency Usage Authorisation clears the tests to be released in the United States and markets accepting the CE mark showing they comply with Eur